Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.
Teierle SM, Huang Y, Kittai AS, Bhat SA, Grever M, Rogers KA, Zhao W, Jones D, Byrd JC, Avenarius MR, Heerema NA, Woyach JA, Miller CR.
Teierle SM, et al. Among authors: jones d.
Blood Adv. 2023 Dec 12;7(23):7239-7242. doi: 10.1182/bloodadvances.2023010753.
Blood Adv. 2023.
PMID: 37851900
Free PMC article.
No abstract available.